Increased kidney xanthine oxidoreductase activity in salt-induced experimental hypertension

Hypertension

Volumn 32, Issue 5, 1998, Pages 902-906

  Laakso, Juha ^a,b   Mervaala, Eero ^b   Himberg, Jaakko Juhani ^b   Teräväinen, Terttu Liisa ^b   Karppanen, Heikki ^b   Vapaatalo, Heikki ^b   Lapatto, Risto ^a,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Allopurinol; Hypertension, essential; Hypertrophy; Rats, Dahl; Rats, inbred SHR; Sodium; Xanthine oxidoreductase

Indexed keywords

XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INDUCTION; EXPERIMENTAL MODEL; HYPERTENSION; KIDNEY; MALE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

EID: 0031740025     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.32.5.902     Document Type: Article

References (30)

1. Mervaala EMA, Himberg J-J, Laakso J, Tuomainen P, Karppanen H. Beneficial effects of a potassium- and magnesium-enriched salt alternative. Hypertension. 1992;19:535-540.
2. Mervaala EMA, Laakso J, Vapaatalo H, Karppanen H. Improvement of cardiovascular effects of metoprolol by replacement of common salt with a potassium- and magnesium-enriched salt alternative. Br J Pharmacol. 1994;112:640-648.
3. McCormick C, Rauch A, Buckalew V. Differential effect of dietary salt on renal growth in Dahl salt-sensitive and salt-resistant rats. Hypertension. 1989;13:122-127.
4. Rettig R, Schmitt B, Pelzi B, Speck T. The kidney and primary hypertension: contributions from renal transplantation studies in animals and humans. J Hypertens. 1993;11:883-891.
5. Morgan DA, DiBona GF, Mark AL. Effects of interstrain renal transplantation on NaCl-induced hypertension in Dahl rats. Hypertension. 1990; 15:436-442.
6. Roman RJ. Abnormal renal hemodynamics and pressure natriuresis relationship in Dahl salt-sensitive rats. Am J Physiol. 1986;251:F57-F65.
7. Cannon PJ, Stason WB, Demartini FE, Sommers SC, Laragh JH. Hyperuricemia in primary and renal hypertension. N Engl J Med. 1981;275: 457-464.
8. Prebis JW, Gruskin AB, Polinsky MS, Beluarte HJ. Uric acid and childhood essential hypertension. J Pediatr. 1981;98:702-709.
9. Newaz MA, Adeeb NNN, Muslim N, Razak TA, Htut NN. Uric acid, xanthine oxidase and other risk factors of hypertension in normotensive subjects. Clin Exp Hypertens. 1996;18:1035-1050.
10. Kooij A. A re-evaluation of the tissue distribution and physiology of xanthine oxidoreductase. Histochem J. 1994;26:889-915.
11. Panus PC, Wright SA, Chumley PH, Radi R, Freeman BA. The contribution of vascular endothelial xanthine dehydrogenase/oxidase to oxygen mediated injury. Arch Biochem Biophys. 1992;294:695-702.
12. Beckman JSD, Parks DA, Pearson JD, Marshall PA, Freeman B. A sensitive fluorometric assay for measuring xanthine dehydrogenase and oxidase in tissues. Free Radic Biol Med. 1989;6:607-615.
13. Schurek HJ, Jost U, Baumgartl H, Bertram H, Heckman U. Evidence for a preglomerular oxygen diffusion shunt in rat renal cortex. Am J Physiol. 1990;259:F910-F915.
14. Brezis M, Epstein FH. Pathophysiology of acute renal failure. In: Hook JB, Goldstein RS, eds. Toxicology of the Kidney, 2nd ed. New York, NY: Raven Press Publishers; 1993:129-152.
15. Arendshost WJ, Beierswaltes WH. Renal and nephron hemodynamics in spontaneously hypertensive rats. Am J Physiol. 1979;236:F246-F251.
16. Orbetzova VT, Kiprov D, Puchlev A. Coenzyme alterations in rats with experimental hypertension. Res Exp Med (Berlin). 1976;167:61-70.
17. Orbetzova V, Kiprov D. Effect of cholesterol-rich diet on the content of nicotinamide nucleotides, adenine nucleotides and acetyl-CoA in the liver, the vascular wall and the kidney of spontaneously hypertensive rats (SHR). Cor Vasa. 1979;21:353-362.
18. Brazy PC, Klotman PE. Increased oxidative metabolism in renal tubules from spontaneously hypertensive rats. Am J Physiol. 1989;257: F818-F825.
19. Hassoun PM, Yu FS, Shedd AL, Zulueta JJ, Thannickal VJ, Lanzillo JJ, Fanburg BL. Regulation of endothelial cell xanthine dehydrogenase/ xanthine oxidases gene expression by oxygen tension. Am J Physiol. 1994;266:L163-L171.
20. Miyamoto Y, Akaike T, Yoshida M, Goto S, Horie H, Maeda H. Potentiation of nitric oxide-mediated vasorelaxation by xanthine oxidase inhibitors. Proc Soc Exp Biol Med. 1996;211:366-373.
21. Suzuki Y, Sudo J-I, Tanabe T. Allopurinol toxicity: its toxic organspecificity between the liver and the kidney in the rat. J Toxicol Sci. 1984;9:343-351.
22. Trachtman H, Valderrama E, Futterweit S. Nephrotoxicity of allopurinol is enhanced in experimental hypertension. Hypertension. 1991;17: 194-202.
23. Suzuki H, DeLano FA, Parks DA, Jamshidi N, Granger DN, Ishi H, Suematsu M, Zweifach BW, Schmid-Schönbein BW. Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc Natl Acad Sci U S A. 1998;95:4754-4759.
24. Parks DA, Granger DN. Xanthine oxidase: biochemistry, distribution and physiology. Acta Physiol Scand Suppl. 1986;548:87-99.
25. Suzuki H, Swei A, Zweifach BW, Schmid-Schönbein GW. In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats: hydroethidine microfluorography. Hypertension. 1995;25: 1083-1089.
26. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol. 1996;271:C1424-C1437.
27. Swei A, Lacy F, DeLano FA, Schmid-Schönbein GW. Oxidative stress in the Dahl hypertensive rat. Hypertension. 1997;30:1628-1633.
28. Omar BA, Flores SC, McCord JM. Superoxide dismutase: pharmacological developments and applications. Adv Pharmacol. 1992;23: 109-161.
29. Anderson RF, Patel KB, Reghebi K, Hill SA. Conversion of xanthine dehydrogenase to xanthine oxidase as a possible marker for hypoxia in tumours and normal tissues. Br J Cancer. 1989;60:193-197.
30. Fredericks WM, Bosch KS. The proportion of xanthine oxidase activity of total xanthine oxidoreductase activity in situ remains constant in rat liver under various (patho)physiological conditions. Hepatology. 1996; 24:1179-1184.